LOX rises as a potential survival biomarker: A commentary on “Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme” by Liu et al.
Author:
Eduardo Silva-Pavez,Hery Urra
Publication:
Translational Oncology
© 2023 The Authors. Published by Elsevier Inc.